Elisabeth Leiderman

Insider Reports History

Entity
Individual
Location
1325 Boylston Street, Suite 500, Boston, MA
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elisabeth Leiderman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
bluebird bio, Inc. Director Common Stock 47.2K $24.8K $0.53 Nov 6, 2024 Direct
Decibel Therapeutics, Inc. Chief Financial Officer Stock Options (right to buy) 52.5K Feb 25, 2022 Direct
bluebird bio, Inc. Director Stock Option (right to buy) 49.9K Nov 6, 2024 Direct

Insider Reports Filed by Elisabeth Leiderman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLUE bluebird bio, Inc. Nov 6, 2024 2 $0 4 Nov 8, 2024 Director
BLUE bluebird bio, Inc. Jun 16, 2023 2 $0 4 Jun 20, 2023 Director
BLUE bluebird bio, Inc. Oct 17, 2022 1 -$6.49K 4 Mar 9, 2023 Director
BLUE bluebird bio, Inc. Jun 22, 2022 2 $0 4 Jun 23, 2022 Director
DBTX Decibel Therapeutics, Inc. Feb 25, 2022 1 $0 4 Feb 28, 2022 Chief Financial Officer
BLUE bluebird bio, Inc. Nov 11, 2021 2 $0 4 Nov 16, 2021 Director
BLUE bluebird bio, Inc. Oct 15, 2021 2 $0 4 Oct 19, 2021 Director
BLUE bluebird bio, Inc. Oct 15, 2021 0 $0 3 Oct 19, 2021 Director